AUSTIN, TX, Accelsius, the leader in two-phase, direct-to-chip liquid cooling for AI and high-performance computing, announced the closing of its Series B funding round, raising $65 million. Read More
DENVER, CO, Neuramint, the leading AI agent platform empowering developers to build and manage autonomous Web3 workflows, announced the successful completion of its $5 million seed funding round. Read More
JERSEY CITY, NJ, Synchrony Medical, a respiratory care technology company, announced it has secured additional funding through a $1M investment from the New Jersey Innovation Evergreen Fund. Read More
ROCHESTER, MN, Cytotheryx, a preclinical cell therapy company developing cell-based treatments for liver disease, announced a $60 million Series A financing. Read More
SAN MATEO, CA, EpiBiologics, a leader in tissue-selective extracellular protein degradation, announced the completion of a $107 million Series B financing. Read More
DENVER, CO, Torq, the established Agentic AI security operations pioneer, announced it has closed a massive $140 million Series D funding round. Read More
WATERTOWN, MA, Diagonal Therapeutics, a biotechnology company, announced the closing of an oversubscribed $125 million Series B financing co-led by Sanofi Ventures and Janus Henderson Investors. Read More
CAMBRIDGE, MA, Parabilis Medicines, a clinical-stage biopharmaceutical company, announced the successful closing of a $305 million Series F financing. Read More